Clinical trial
Can Recombinant Human Intrinsic Factor Be Used for Evaluation of the Vitamin B12…
NCT00279552 · University of Aarhus, Other · Completed
Key facts
| NCT number | NCT00279552 |
|---|---|
| Title | Can Recombinant Human Intrinsic Factor Be Used for Evaluation of the Vitamin B12 Absorption? |
| Official title | Can Recombinant Human Intrinsic Factor Be Used for Evaluation of the Vitamin B12 Absorption? |
| Lead sponsor | University of Aarhus, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Vitamin B12 Deficiency |
| Intervention type | Drug |
| Interventions | Recombinant human intrinsic factor |
| Enrollment | 37 |
| Start date | Apr 1, 2004 |
| Completion | Dec 1, 2004 |
| First posted | Jan 19, 2006 |
| Last update posted | Jan 19, 2006 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: